Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$19.72 -0.59 (-2.90%)
As of: Oct 23, 2026 · 3:39 PM EDT

Acadia Pharmaceuticals (ACAD) Other Accumulated Expenses (2011 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) reported Other Accumulated Expenses of $15.96 million for Q2 2026, up 19.1% from $13.4 million a year earlier but down 1.0% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals posted Other Accumulated Expenses of $5.89 million, up 73.8% from FY2024.

  • Other Accumulated Expenses has a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
  • By year, Other Accumulated Expenses came in at $3.39 million in FY2024 (-69.3%), $11.04 million in FY2023 (+307.5%), $2.71 million in FY2022 (+0.8%) and $2.69 million in FY2021 (-47.5%).
  • Five-year quarterly Other Accumulated Expenses spans a low of $986,000 in Q2 2022 and a high of $16.12 million in Q1 2026.
  • Year over year, Other Accumulated Expenses has now increased in each of the last three quarters, with growth averaging 12.1% over the last eight quarters.
  • The high point for year-over-year Other Accumulated Expenses in five years was Q1 2023 (growth of 777.8%); the low point was Q4 2024 (a decline of 69.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $16.12 million (Q1 2026), $5.89 million (Q4 2025) and $5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.95 Bn 1,100.53 Bn 19.71 Bn
2 Johnson & Johnson 635.80 Bn 555.66 Bn 17.30 Bn
3 AbbVie 506.62 Bn 479.73 Bn 12.70 Bn
4 Merck 358.64 Bn 313.02 Bn 12.21 Bn
5 Novartis Ag 292.18 Bn 256.17 Bn 11.24 Bn
6 Astrazeneca 265.70 Bn 239.39 Bn 12.86 Bn
7 Amgen 237.74 Bn 193.14 Bn 7.24 Bn
8 Gilead Sciences 195.25 Bn 169.45 Bn 6.22 Bn
9 Pfizer 171.25 Bn 117.90 Bn 10.94 Bn
10 Acadia Pharmaceuticals 3.38 Bn -93.20 Mn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.96 Mn
Mar 31, 2026 16.12 Mn
Dec 31, 2025 5.89 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 13.40 Mn
Mar 31, 2025 9.35 Mn
Dec 31, 2024 3.39 Mn
Sep 30, 2024 12.72 Mn
Jun 30, 2024 8.88 Mn
Mar 31, 2024 13.74 Mn
Dec 31, 2023 11.04 Mn
Sep 30, 2023 8.95 Mn
Jun 30, 2023 5.89 Mn
Mar 31, 2023 10.26 Mn
Dec 31, 2022 2.71 Mn
Sep 30, 2022 2.52 Mn
Jun 30, 2022 986,000.00
Mar 31, 2022 1.17 Mn
Dec 31, 2021 2.69 Mn
Sep 30, 2021 2.76 Mn
API Access

Acadia Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY